Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M50,058Revenue (TTM) $M10,936Net Margin (%)33.8Altman Z-Score5.4
Enterprise Value $M53,014EPS (TTM) $16.3Operating Margin %47.1Piotroski F-Score5
P/E(ttm)14.0Beneish M-Score-3.0Pre-tax Margin (%)45.6Higher ROA y-yN
Price/Book4.910-y EBITDA Growth Rate %25.9Quick Ratio2.3Cash flow > EarningsY
Price/Sales4.85-y EBITDA Growth Rate %30.0Current Ratio2.6Lower Leverage y-yN
Price/Free Cash Flow16.0y-y EBITDA Growth Rate %16.4ROA % (ttm)19.9Higher Current Ratio y-yN
Dividend Yield %--PEG0.5ROE % (ttm)33.9Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M219ROIC % (ttm)33.5Gross Margin Increase y-yY

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBRonald Muhlenkamp 2016-03-31 Buy 2.53%$245.11 - $306.35
($264.69)
$ 228.52-14%New holding23,853
BIIBJoel Greenblatt 2016-03-31 Add0.62%$245.11 - $306.35
($264.69)
$ 228.52-14%Add 253.14%298,673
BIIBJohn Paulson 2016-03-31 Add0.16%$245.11 - $306.35
($264.69)
$ 228.52-14%Add 227.07%118,400
BIIBFirst Eagle Investment 2016-03-31 Add0.02%$245.11 - $306.35
($264.69)
$ 228.52-14%Add 15.83%224,585
BIIBKen Fisher 2016-03-31 Reduce-0.01%$245.11 - $306.35
($264.69)
$ 228.52-14%Reduce -18.17%90,405
BIIBRon Baron 2016-03-31 Add0.01%$245.11 - $306.35
($264.69)
$ 228.52-14%Add 56.71%16,047
BIIBMario Gabelli 2016-03-31 Add$245.11 - $306.35
($264.69)
$ 228.52-14%Add 0.10%4,810
BIIBJoel Greenblatt 2015-12-31 Add0.25%$256.04 - $309.67
($287.66)
$ 228.52-21%Add 798.80%84,577
BIIBFirst Eagle Investment 2015-12-31 Buy 0.15%$256.04 - $309.67
($287.66)
$ 228.52-21%New holding193,885
BIIBVanguard Health Care Fund 2015-12-31 Add0.09%$256.04 - $309.67
($287.66)
$ 228.52-21%Add 3.91%3,810,023
BIIBJohn Paulson 2015-12-31 Buy 0.07%$256.04 - $309.67
($287.66)
$ 228.52-21%New holding36,200
BIIBKen Fisher 2015-12-31 Reduce$256.04 - $309.67
($287.35)
$ 228.52-20%Reduce -1.75%110,475
BIIBMario Gabelli 2015-12-31 Add$256.04 - $309.67
($287.66)
$ 228.52-21%Add 0.17%4,805
BIIBRon Baron 2015-12-31 Reduce$256.04 - $309.67
($287.66)
$ 228.52-21%Reduce -13.32%10,240
BIIBVanguard Health Care Fund 2015-09-30 Add1.19%$272.28 - $409.5
($330.23)
$ 228.52-31%Add 105.96%3,666,723
BIIBJoel Greenblatt 2015-09-30 Buy 0.03%$272.28 - $409.5
($330.23)
$ 228.52-31%New holding9,410
BIIBKen Fisher 2015-09-30 Add0.02%$272.28 - $409.5
($330.23)
$ 228.52-31%Add 38.94%112,448
BIIBRon Baron 2015-09-30 Add$272.28 - $409.5
($330.23)
$ 228.52-31%Add 29.20%11,814
BIIBVanguard Health Care Fund 2015-06-30 Add1.17%$373.93 - $430.96
($401.66)
$ 228.52-43%Add 425.02%1,780,330
BIIBMario Gabelli 2015-06-30 Reduce$373.93 - $430.96
($401.66)
$ 228.52-43%Reduce -2.74%4,797
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Koppel AdamEVP, Strategy and Bus. Dev. 2016-06-06Sell555$290-21.2view
SCANGOS GEORGE ACEO 2016-06-03Sell842$290-21.2view
SCANGOS GEORGE ACEO 2016-06-01Sell3,855$289.74-21.13view
SCANGOS GEORGE ACEO 2016-05-25Sell157$280-18.39view
SCANGOS GEORGE ACEO 2016-05-02Sell487$274.74-16.82view
Koppel AdamEVP, Strategy and Bus. Dev. 2016-04-06Sell102$275-16.9view
SCANGOS GEORGE ACEO 2016-04-06Sell157$280-18.39view
SCANGOS GEORGE ACEO 2016-04-01Sell487$258.83-11.71view
SCANGOS GEORGE ACEO 2016-03-01Sell487$261.37-12.57view
Sandrock AlfredEVP CMO Neuro & Neurodegenerat 2016-02-25Sell183$261.9-12.75view

Press Releases about BIIB :

Quarterly/Annual Reports about BIIB:

News about BIIB:

Articles On GuruFocus.com
The Neglected Biogen Jun 13 2016 
5 Attractive Biotechnology Stocks for Healthy Long-term Returns Jun 10 2016 
High Quality Stocks Gurus Are Buying Jun 07 2016 
Joel Greenblatt Bets on eBay, Intel, Biogen Jun 03 2016 
Jeff Auxier's Spring 2016 Market Commentary May 20 2016 
Richard Snow Boosts Biogen, Keysight Technologies May 12 2016 
10 Years of Strong Returns: Priceline, Biogen Apr 26 2016 
Alaska Air, Delta and NVR Make the 30-30 Club Apr 15 2016 
Undervalued Stocks With Wide Margin of Safety Apr 14 2016 
John Buckingham Trades in ETFs in 4th Quarter Mar 15 2016 

More From Other Websites
Smart Chart Reading: Look For Solid Accumulation In A Base Jun 28 2016
5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero Jun 28 2016
Biogen, Inc. :BIIB-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 Jun 28 2016
Biotechs: After Brexit, Buy the Stocks and Get the Pipelines For Free Jun 28 2016
How Medical Researchers Are Breaking the Blood-Brain Barrier Jun 28 2016
Biogen Selects Cognizant's SmartTrials Platform Jun 28 2016
Biogen Selects Cognizant's SmartTrials Platform Jun 28 2016
The Largest Drug Pipelines Will Surprise You Jun 27 2016
A Biotech Stock Turnaround Requires an Alzheimer's Drug Miracle Jun 27 2016
Alexion Pharmaceuticals: Brexit Be Damned; Citigroup Ups to Buy Citing "Dark Sky Valuation" Jun 27 2016
Is Brexit Good for Biotech? Maybe Jun 27 2016
Short Sellers Run for Cover From Major Biotechs Jun 27 2016
Think of This Stock as Buy-ogen Jun 25 2016
Biotech: Buy the Brexit Blowup? Jun 24 2016
Brexit means little for biotech stocks, analyst says Jun 24 2016
The Largest and Most Absurd Stock Buybacks Jun 23 2016
Verifone, Biogen Crash Wednesday’s 52-Week Low Club Jun 22 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)